MACROGENICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 18.80K shares.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 4.23K shares.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 333.52K shares, a 863.71% increase from fiscal 2023.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 34.61K shares, a 71.37% decline from fiscal 2022.
- MACROGENICS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 120.90K shares, a 63.67% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 18.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 23.03K shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 4.23K shares 10-Q · filed 2026-05-13 | 4.23K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 0.00 shares 10-K · filed 2026-03-09 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 1.61K shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 2.88K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-13 | 75.84K shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 1.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 333.52K shares 10-K · filed 2025-03-20 |
| 2024-09-30 | 1.27K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | 340.38K shares derived: sum of 4 quarters · filed 2024-11-05 |
| 2024-06-30 | 72.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 350.26K shares derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | 257.68K shares 10-Q · filed 2024-05-09 | 288.76K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 8.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 34.61K shares 10-K · filed 2024-03-07 |
| 2023-09-30 | 11.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 64.08K shares derived: sum of 4 quarters · filed 2023-11-06 |
| 2023-06-30 | 11.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 55.17K shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 3.53K shares 10-Q · filed 2023-05-09 | 98.78K shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 37.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 120.90K shares 10-K · filed 2023-03-15 |
| 2022-09-30 | 2.24K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 113.08K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 55.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 163.31K shares derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | 25.65K shares 10-Q · filed 2022-05-03 | 214.16K shares derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-12-31 | 30.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 332.77K shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 52.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 358.36K shares derived: sum of 4 quarters · filed 2021-11-02 |
| 2021-06-30 | 105.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | 425.03K shares derived: sum of 4 quarters · filed 2021-07-29 |
| 2021-03-31 | 144.25K shares 10-Q · filed 2021-04-29 | 476.31K shares derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | 55.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 504.44K shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 119.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | 457.52K shares derived: sum of 4 quarters · filed 2020-11-04 |
| 2020-06-30 | 157.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | 359.21K shares derived: sum of 4 quarters · filed 2020-07-31 |
| 2020-03-31 | 172.39K shares 10-Q · filed 2020-05-05 | 264.73K shares derived: sum of 4 quarters · filed 2020-05-05 |
| 2019-12-31 | 8.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 219.04K shares 10-K · filed 2020-02-25 |
| 2019-09-30 | 20.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 289.79K shares derived: sum of 4 quarters · filed 2019-11-06 |
| 2019-06-30 | 62.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | 289.09K shares derived: sum of 4 quarters · filed 2019-07-31 |
| 2019-03-31 | 126.71K shares 10-Q · filed 2019-05-01 | 235.52K shares derived: sum of 4 quarters · filed 2019-05-01 |
| 2018-12-31 | 79.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 285.43K shares 10-K · filed 2019-02-26 |
| 2018-09-30 | 20.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 239.21K shares derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | 9.16K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 283.32K shares derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | 176.62K shares 10-Q · filed 2018-05-07 | 319.83K shares derived: sum of 4 quarters · filed 2018-05-07 |
| 2017-12-31 | 33.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 253.04K shares 10-K · filed 2018-02-27 |
| 2017-09-30 | 64.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 277.00K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-06-30 | 45.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 332.05K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2017-03-31 | 109.83K shares 10-Q · filed 2017-05-03 | 445.67K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-12-31 | 57.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 526.72K shares 10-K · filed 2018-02-27 |
| 2016-09-30 | 119.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | 566.96K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | 159.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | 518.74K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | 190.87K shares 10-Q · filed 2016-05-04 | 459.26K shares derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | 97.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | 374.21K shares 10-K · filed 2018-02-27 |
| 2015-09-30 | 71.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | 538.40K shares derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | 99.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | 506.95K shares derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | 105.82K shares 10-Q · filed 2015-05-06 | 640.45K shares derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | 261.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 568.91K shares 10-K · filed 2017-02-28 |
| 2014-09-30 | 39.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | 549.32K shares derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | 233.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | |
| 2014-03-31 | 34.27K shares 10-Q · filed 2014-05-06 | |
| 2013-12-31 | 242.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | 1.27M shares 10-K · filed 2016-02-29 |
| 2012-12-31 | 863.18K shares 10-K · filed 2015-03-03 | |
| 2011-12-31 | 49.88K shares 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |